Treatment of multiple sclerosis with combination of laquinimod and glatiramer acetate

• 1. 用拉喹莫德与醋酸格拉替雷的组合治疗多发性硬化症 [P] . 中国专利： CN105944081A . 2016-09-21
• 2. 用拉喹莫德与醋酸格拉替雷的组合治疗多发性硬化症 [P] . 中国专利： CN103781354A . 2014-05-07
• 3. multiple sclerosis treatment with combination of laquinimod and glatiramer acetate [P] . BR112014002095A2 . 2017-02-21

  机译： 拉喹莫德和醋酸格拉替雷联合治疗多发性硬化症

• 4. TREATMENT OF MULTIPLE SCLEROSIS IN COMBINATION WITH LAQUINIMOD AND GLATIRAMER ACETATE [P] . 日本专利： JP2017081930A . 2017-05-18

  机译： 拉米尼莫德和醋酸格拉默联合治疗多发性硬化症

• 5. TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE [P] . AU2016204777A1 . 2016-07-28

  机译： 拉米尼莫德和醋酸格拉默酯联合治疗多发性硬化症

• 1. Role of CD20+ T cells in multiple sclerosis: implications for treatment with ocrelizumab [J] . Stefan Gingele, Thomas Skripuletz, Roland Jacobs 中国神经再生研究（英文版） . 2020,第004期
• 2. Environmental enrichment as a promising strategy for aiding multiple sclerosis treatment [J] . Berenice Anabel Silva, Carina Cintia Ferrari 中国神经再生研究（英文版） . 2020,第009期
• 3. On the road to new treatments for multiple sclerosis: targeting dendritic cell migration into the central nervous system [J] . Megha Meena, Nathalie Cools 中国神经再生研究（英文版） . 2019,第012期
• 4. Multiple Sclerosis and Treatment： Drug Management and Nutrition with Exercise [J] . Hector Melissinos 药剂与药理学：英文版 . 2017,第012期
• 5. Soluble interleukin 23 receptor gene therapy with adeno-associated vectors for the treatment of multiple sclerosis [J] . Ángel Edo 中国神经再生研究（英文版） . 2017,第010期
• 6. Short-term combination of glatiramer acetate with IV steroid treatment preceding treatment with GA alone assessed by MRI-disease activity in patients with relapsing-remitting multiple sclerosis. [J] . De-Stefano N, Filippi M, Hawkins C Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology . 2008,第1a2期
• 7. Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis (vol 72, pg 1411, 2015) [J] . Bourdette D., Hartung D. JAMA neurology . 2015,第12期
• 8. Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis [J] . Bourdette Dennis, Hartung Daniel JAMA neurology . 2015,第12期
• 9. Using a Combination of Artificial Neural Networks for the Diagnosis of Multiple Sclerosis [C] . Angel GUTIERREZ, Carlos FERNANDEZ GARCiA World multi-conference on systemics, cybernetics and informatics;WMSCI 2011 . 2012
• 10. Imaging Informatics-Based Electronic Patient Record and Analysis System for Multiple Sclerosis Research, Treatment, and Disease Tracking [D] . Ma, Kevin C. 2018
• 11. Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple sclerosis treatment [O] . Matteo Caporro, Giulio Disanto, Claudio Gobbi, 2014
• 12. Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 years [O] . Fred D. Lublin, Stacey S. Cofield, Gary R. Cutter, 2017

• 1. 万古霉素糖基转移酶GtfE在雷莫拉宁产生菌中的异源表达与鉴定 [C] . 王元希 ,林惠敏 ,陈俊升 . 第十二届全国抗生素学术会议 . 2013
• 2. 拉喹莫德治疗多发性硬化的系统评价 [A] . 李荣杰 . 2013